Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.

Calcium-independent phospholipase A2γ (iPLA2γ) is localized in glomerular epithelial cells (GECs)/podocytes at the mitochondria and endoplasmic reticulum, and can mediate release of arachidonic acid and prostanoids. Global knockout (KO) of iPLA2γ in mice did not cause albuminuria, but resulted in mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrey V Cybulsky, Joan Papillon, Julie Guillemette, José R Navarro-Betancourt, Hanan Elimam, I George Fantus
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0311404
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772841272082432
author Andrey V Cybulsky
Joan Papillon
Julie Guillemette
José R Navarro-Betancourt
Hanan Elimam
I George Fantus
author_facet Andrey V Cybulsky
Joan Papillon
Julie Guillemette
José R Navarro-Betancourt
Hanan Elimam
I George Fantus
author_sort Andrey V Cybulsky
collection DOAJ
description Calcium-independent phospholipase A2γ (iPLA2γ) is localized in glomerular epithelial cells (GECs)/podocytes at the mitochondria and endoplasmic reticulum, and can mediate release of arachidonic acid and prostanoids. Global knockout (KO) of iPLA2γ in mice did not cause albuminuria, but resulted in mitochondrial structural abnormalities and enhanced autophagy in podocytes. In acute glomerulonephritis, deletion of iPLA2γ exacerbated albuminuria and podocyte injury. This study addresses the role of iPLA2γ in diabetic nephropathy. Hyperglycemia was induced in male mice with streptozotocin (STZ). STZ induced progressive albuminuria in control mice (over 21 weeks), while albuminuria did not increase in iPLA2γ KO mice, remaining comparable to untreated groups. Despite similar exposure to STZ, the STZ-treated iPLA2γ KO mice developed a lower level of hyperglycemia compared to STZ-treated control. However, there was no significant correlation between the degree of hyperglycemia and albuminuria, and even iPLA2γ KO mice with greatest hyperglycemia did not develop significant albuminuria. Mortality at 21 weeks was greatest in diabetic control mice. Sclerotic glomeruli and enlarged glomerular capillary loops were increased significantly in diabetic control compared to diabetic iPLA2γ KO mice. Glomerular matrix was expanded in diabetic mice, with control exceeding iPLA2γ KO. Glomerular autophagy (increased LC3-II and decreased p62) was enhanced in diabetic iPLA2γ KO mice compared to control. Treatment of cultured GECs with H2O2 resulted in increased cell death in control GECs compared to iPLA2γ KO, and the increase was slightly greater in medium with high glucose compared to low glucose. H2O2-induced cell death was not affected by inhibition of prostanoid production with indomethacin. In conclusion, mice with global deletion of iPLA2γ are protected from developing chronic glomerular injury in diabetic nephropathy. This is associated with increased glomerular autophagy.
format Article
id doaj-art-7cf7d715aee546cd8049cbfd80fa4bfa
institution DOAJ
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-7cf7d715aee546cd8049cbfd80fa4bfa2025-08-20T03:02:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011910e031140410.1371/journal.pone.0311404Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.Andrey V CybulskyJoan PapillonJulie GuillemetteJosé R Navarro-BetancourtHanan ElimamI George FantusCalcium-independent phospholipase A2γ (iPLA2γ) is localized in glomerular epithelial cells (GECs)/podocytes at the mitochondria and endoplasmic reticulum, and can mediate release of arachidonic acid and prostanoids. Global knockout (KO) of iPLA2γ in mice did not cause albuminuria, but resulted in mitochondrial structural abnormalities and enhanced autophagy in podocytes. In acute glomerulonephritis, deletion of iPLA2γ exacerbated albuminuria and podocyte injury. This study addresses the role of iPLA2γ in diabetic nephropathy. Hyperglycemia was induced in male mice with streptozotocin (STZ). STZ induced progressive albuminuria in control mice (over 21 weeks), while albuminuria did not increase in iPLA2γ KO mice, remaining comparable to untreated groups. Despite similar exposure to STZ, the STZ-treated iPLA2γ KO mice developed a lower level of hyperglycemia compared to STZ-treated control. However, there was no significant correlation between the degree of hyperglycemia and albuminuria, and even iPLA2γ KO mice with greatest hyperglycemia did not develop significant albuminuria. Mortality at 21 weeks was greatest in diabetic control mice. Sclerotic glomeruli and enlarged glomerular capillary loops were increased significantly in diabetic control compared to diabetic iPLA2γ KO mice. Glomerular matrix was expanded in diabetic mice, with control exceeding iPLA2γ KO. Glomerular autophagy (increased LC3-II and decreased p62) was enhanced in diabetic iPLA2γ KO mice compared to control. Treatment of cultured GECs with H2O2 resulted in increased cell death in control GECs compared to iPLA2γ KO, and the increase was slightly greater in medium with high glucose compared to low glucose. H2O2-induced cell death was not affected by inhibition of prostanoid production with indomethacin. In conclusion, mice with global deletion of iPLA2γ are protected from developing chronic glomerular injury in diabetic nephropathy. This is associated with increased glomerular autophagy.https://doi.org/10.1371/journal.pone.0311404
spellingShingle Andrey V Cybulsky
Joan Papillon
Julie Guillemette
José R Navarro-Betancourt
Hanan Elimam
I George Fantus
Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
PLoS ONE
title Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
title_full Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
title_fullStr Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
title_full_unstemmed Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
title_short Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.
title_sort genetic deletion of calcium independent phospholipase a2γ protects mice from diabetic nephropathy
url https://doi.org/10.1371/journal.pone.0311404
work_keys_str_mv AT andreyvcybulsky geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy
AT joanpapillon geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy
AT julieguillemette geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy
AT josernavarrobetancourt geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy
AT hananelimam geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy
AT igeorgefantus geneticdeletionofcalciumindependentphospholipasea2gprotectsmicefromdiabeticnephropathy